Author

Min Zhang

First Affiliated Hospital Zhejiang UniversityORCID 0000-0002-1644-3012Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Min Zhang6 papers · Fudan University

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cell Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:database / resource· 1

Frequent Co-Authors

Andrew Chung· 1 shared Chenyang WuiD· 1 shared David C He· 1 shared Dongyu ZhaoiD· 1 shared Mukamengjiang JuaitiiD· 1 shared Peng Yan· 1 shared Shaodong Huang· 1 shared Sheng LiiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Andrew Chung

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer Driver Topologically Associated Domains identify oncogenic and tumor suppressive lncRNAs

Ziyan Rao, Min Zhang, Shaodong Huang, Chenyang Wu, Yuheng Zhou, Weijie Zhang, Xia Lin, Dongyu Zhao

The paper identifies cancer driver lncRNAs by analyzing their association with cancer driver genes and topologically associated domains, revealing 256 oncogenic, 177 tumor suppressive, and 75 dual-function lncRNAs.

Genome Research · Aug 1, 2025Peer-reviewedGenomics

The Cardioprotective Effect of Ischemic Postconditioning is Mediated by Inhibiting RAP2C-MAP4K4 Pathway

Peng Yan, Zaixin Yu, Zhiqiang Hu, Sheng Li, Mukamengjiang Juaiti, Min Zhang

This study shows ischemic postconditioning reduces cardiomyocyte apoptosis by inhibiting the RAP2C-MAP4K4 pathway, suggesting it as a therapeutic target for ischemic heart disease.

bioRxiv · Dec 4, 2024 · PreprintCell Biology

Identification of transcriptional landscapes and functions of the inhibition of ARHGEF2 in hepatocellular carcinoma cells

Min Zhang, David C He, Andrew Chung

This study identifies the transcriptional changes and signaling pathways affected by ARHGEF2 inhibition in hepatocellular carcinoma cells, highlighting AD and CS pathways and key interacting genes.

bioRxiv · Aug 18, 2022 · PreprintBioinformatics